Notice: Function _load_textdomain_just_in_time was called incorrectly. Translation loading for the wordpress-seo domain was triggered too early. This is usually an indicator for some code in the plugin or theme running too early. Translations should be loaded at the init action or later. Please see Debugging in WordPress for more information. (This message was added in version 6.7.0.) in /var/www/html/wp-includes/functions.php on line 6260 PharmaIN, Shionogi & Co. Enter Collaboration Agreement | Contract Pharma

What are you searching for?

Sign in
Breaking News, Collaborations & Alliances

PharmaIN, Shionogi & Co. Enter Collaboration Agreement

Shionogi will make an equity investment of up to $17M in PharmaIN

By: Betsy Louda

, Contract Pharma

PharmaIN Corporation and Shionogi & Co. have entered into a collaboration agreement with an exclusive two-year option to negotiate a license for the collaboration product.  

 

Shionogi Corp. will make an equity investment of up to $17M in PharmaIN in three transactions.

 

“We’ve enjoyed working with Shionogi since initial proof of concepts and are excited to expand our collaboration to advance novel, first in class therapy to benefit many millions of patients.  As a major research-driven pharmaceutical company Shionogi brings valuable experience, resources and innovation to our partnership,” said Elijah Bolotin, PhD, president and chief executive officer of PharmaIN Corp.

 

“Shionogi is very pleased to start this collaboration with PharmaIN, which has innovative platform technologies for drug discovery of various molecules including peptides, proteins and small molecules. We look forward to this collaboration that will surely bring us the great opportunity to provide many patients with innovative medicines,” said Takeshi Shiota, PhD, corporate officer, senior vice president, Pharmaceutical Research Division.

Add us as a preferred source on Google

Get the latest Contract Pharma news, insights and analysis in your Google Search and AI experiences.

Add Contract Pharma as a preferred source on Google (opens in a new tab)

Keep Up With Our Content. Subscribe To Contract Pharma Newsletters

Topics